CMSLocal Coverage Determination (LCD)

CMS Ionized Calcium Form


Ionized Calcium Test

Notes: Coverage is determined by local coverage determinations (LCDs) and may require that the procedure be reasonable and necessary as outlined in the Social Security Act Section 1862 (a)(1)(A).

Indications

(180948) Is the patient showing clinical signs and symptoms of hyperparathyroidism such as weakness, fatigue, bone pain, confusion, depression, nausea, vomiting, polyuria, etc.? 
(180949) Is the patient exhibiting signs of hypoparathyroidism including Chvostek’s sign, Trousseau’s sign, dysphagia, tetany, or increased deep tendon reflexes? 
(180950) Does the patient have an abnormal total calcium level? 
(180951) Is the patient being monitored for renal disease, post-renal transplantation, or undergoing hemodialysis? 
(180952) Has the patient been previously diagnosed with hyperparathyroidism or hypoparathyroidism? 

YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

10/01/2019

Last Reviewed

10/02/2019

Original Document

  Reference



Background for this Policy

Summary Of Evidence

N/A

Analysis of Evidence

N/A

History/Background and/or General Information

Ionized calcium is a cation that circulates freely in the bloodstream and comprises 46-50% of all circulating calcium. Only the ionized calcium can be used by the body in such vital processes as muscular contraction, cardiac function, transmission of nerve impulses, and blood clotting. Ionized calcium is considered a more sensitive and accurate indicator for many operative procedures and disease processes. A normal serum ionized calcium for an adult is 4.65 - 5.28 mg/dl.

Covered Indications

An Ionized Calcium test will be considered medically necessary under any of the following circumstances:

  • Evaluation of patients with clinical signs and symptoms of hyperparathyroidism such as weakness, fatigue, bone pain, confusion, depression, nausea, vomiting, polyuria, etc. in which parathyroid disease is suspected;
  • Evaluation of patients with clinical signs and symptoms of hypoparathyroidism such as Chvostek’s sign, Trousseau’s sign, dysphagia, tetany, increased deep tendon reflexes, etc. in which parathyroid disease is suspected;
  • Evaluation of a patient with an abnormal total calcium level;
  • Monitoring of a patient with renal disease, renal transplantation, or hemodialysis;
  • Patients with previously diagnosed hyper or hypoparathyroidism;
  • Patients with pancreatitis as characterized by symptoms such as epigastric abdominal pain, nausea and/or vomiting, fever, hypotension, mild jaundice, umbilical discoloration (Cullen’s sign), etc.;
  • Patients with a magnesium deficiency and/or excessive Vitamin D;
  • Patients with sepsis as characterized by symptoms such as hypotension, tachycardia, tachypnea, change in mental status, etc.; and
  • Patients with ectopic parathyroid hormone producing neoplasms.

Limitations

As published in the CMS IOM Publication 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.4, an item or service may be covered by a contractor LCD if it is reasonable and necessary under the Social Security Act Section 1862 (a)(1)(A). Contractors shall determine and describe the circumstances under which the item or service is considered reasonable and necessary.